Format

Send to

Choose Destination
Trends Microbiol. 1995 Dec;3(12):469-74.

Vaccines for gonorrhea: where are we on the curve?

Author information

1
University of Iowa, College of Medicine, Department of Microbiology, Iowa City, Iowa, USA.

Abstract

Human antibodies that bind the gonococcal outer membrane modulate gonorrheal transmission and disease. The effects of antibody binding can favor either the host or the bacteria, and depend on the antigen involved. An effective gonococcal vaccine is feasible, but only by the careful selection and formulation of gonococcal antigens that elicit only host-protective antibodies.

PMID:
8800838
DOI:
10.1016/s0966-842x(00)89012-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center